Latest Articles

Publication Date
All News Scientific
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Adelaide Now

Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Adelaide Now

Published: May 18, 2026, 5:52 p.m.
Read Full Article
‘I am truly grateful’: Endometriosis care, fertility treatment make motherhood possible - UChicago Medicine

‘I am truly grateful’: Endometriosis care, fertility treatment make motherhood possible UChicago Medicine

Published: May 18, 2026, 4:39 p.m.
Read Full Article
Sinn Féin to hold Endometriosis event - sinnfein.ie

Sinn Féin to hold Endometriosis event sinnfein.ie

Published: May 18, 2026, 4:01 p.m.
Read Full Article
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Herald Sun

Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Herald Sun

Published: May 18, 2026, 3:08 p.m.
Read Full Article
Easing pain: Way to slash endometriosis diagnosis by years - NT News

Easing pain: Way to slash endometriosis diagnosis by years NT News

Published: May 18, 2026, 2:19 p.m.
Read Full Article
Merck reports positive Phase 3 results for uterine cancer drug - Voice of Healthcare

Merck reports positive Phase 3 results for uterine cancer drug Voice of Healthcare

Published: May 18, 2026, 11:29 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Pontefract woman made 30 A&E visits before endometriosis diagnosis after being told it was 'all in her head' - Yorkshire Live

Pontefract woman made 30 A&E visits before endometriosis diagnosis after being told it was 'all in her head' Yorkshire Live

Published: May 18, 2026, 10:35 a.m.
Read Full Article
What it's like living with Ehlers-Danlos syndrome on P.E.I. - CBC

What it's like living with Ehlers-Danlos syndrome on P.E.I. CBC

Published: May 18, 2026, 6:44 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!